Biodexa Pharmaceticals Stock Price Patterns
| BDRX Stock | 1.30 0.15 10.34% |
Momentum 39
Sell Extended
Oversold | Overbought |
EPS Estimate Current Year (0.40) | EPS Estimate Next Year (0.10) | Wall Street Target Price 178.3005 | Quarterly Revenue Growth (0.64) |
Using Biodexa Pharmaceticals hype-based prediction, you can estimate the value of Biodexa Pharmaceticals from the perspective of Biodexa Pharmaceticals response to recently generated media hype and the effects of current headlines on its competitors.
Biodexa Pharmaceticals Hype to Price Pattern
Investor biases related to Biodexa Pharmaceticals' public news can be used to forecast risks associated with an investment in Biodexa. The trend in average sentiment can be used to explain how an investor holding Biodexa can time the market purely based on public headlines and social activities around Biodexa Pharmaceticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Biodexa Pharmaceticals' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Biodexa Pharmaceticals.
The fear of missing out, i.e., FOMO, can cause potential investors in Biodexa Pharmaceticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Biodexa because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Biodexa Pharmaceticals after-hype prediction price | USD 1.85 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Biodexa Pharmaceticals Basic Forecasting Models to cross-verify your projections. Biodexa Pharmaceticals After-Hype Price Density Analysis
As far as predicting the price of Biodexa Pharmaceticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Biodexa Pharmaceticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Biodexa Pharmaceticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Biodexa Pharmaceticals Estimiated After-Hype Price Volatility
In the context of predicting Biodexa Pharmaceticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Biodexa Pharmaceticals' historical news coverage. Biodexa Pharmaceticals' after-hype downside and upside margins for the prediction period are 0.09 and 19.20, respectively. We have considered Biodexa Pharmaceticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Biodexa Pharmaceticals is somewhat reliable at this time. Analysis and calculation of next after-hype price of Biodexa Pharmaceticals is based on 3 months time horizon.
Biodexa Pharmaceticals Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Biodexa Pharmaceticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Biodexa Pharmaceticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Biodexa Pharmaceticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.96 | 17.35 | 0.53 | 0.03 | 8 Events / Month | 6 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.30 | 1.85 | 42.69 |
|
Biodexa Pharmaceticals Hype Timeline
Biodexa Pharmaceticals is currently traded for 1.30. The entity has historical hype elasticity of 0.53, and average elasticity to hype of competition of 0.03. Biodexa is projected to increase in value after the next headline, with the price projected to jump to 1.855 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 42.69%, whereas the daily expected return is currently at -0.96%. The volatility of related hype on Biodexa Pharmaceticals is about 55967.74%, with the expected price after the next announcement by competition of 1.33. Biodexa Pharmaceticals currently holds 727 K in liabilities. Note, when we think about Biodexa Pharmaceticals' use of debt, we should always consider it together with its cash and equity.Given the investment horizon of 90 days the next projected press release will be in about 8 days. Check out Biodexa Pharmaceticals Basic Forecasting Models to cross-verify your projections.Biodexa Pharmaceticals Related Hype Analysis
Having access to credible news sources related to Biodexa Pharmaceticals' direct competition is more important than ever and may enhance your ability to predict Biodexa Pharmaceticals' future price movements. Getting to know how Biodexa Pharmaceticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Biodexa Pharmaceticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| INM | InMed Pharmaceuticals | 0.03 | 7 per month | 0.00 | (0.15) | 7.48 | (9.30) | 30.84 | |
| GNPX | Genprex | 2.03 | 8 per month | 0.00 | (0.15) | 18.18 | (11.32) | 44.30 | |
| GRI | GRI Bio | 0.28 | 7 per month | 0.00 | (0.33) | 11.88 | (20.75) | 77.14 | |
| JAGX | Jaguar Animal Health | (3.29) | 3 per month | 0.00 | (0.08) | 9.71 | (16.87) | 125.57 | |
| ESLA | Estrella Immunopharma | (0.04) | 5 per month | 0.00 | (0.11) | 12.21 | (15.49) | 50.95 | |
| GLMD | Galmed Pharmaceuticals | 0.02 | 9 per month | 0.00 | (0.22) | 8.04 | (9.20) | 21.39 | |
| CNSP | CNS Pharmaceuticals | (0.08) | 5 per month | 0.00 | (0.14) | 7.22 | (7.95) | 26.44 | |
| BIVI | Biovie Inc | (0.02) | 9 per month | 0.00 | (0.16) | 7.41 | (8.06) | 22.72 | |
| KZIA | Kazia Therapeutics Ltd | 0.84 | 9 per month | 10.23 | 0.01 | 14.69 | (18.36) | 78.79 | |
| CANF | Can Fite Biopharma | 0.54 | 10 per month | 0.00 | (0.11) | 10.40 | (8.59) | 38.42 |
Biodexa Pharmaceticals Additional Predictive Modules
Most predictive techniques to examine Biodexa price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Biodexa using various technical indicators. When you analyze Biodexa charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Biodexa Pharmaceticals Predictive Indicators
The successful prediction of Biodexa Pharmaceticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Biodexa Pharmaceticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Biodexa Pharmaceticals based on analysis of Biodexa Pharmaceticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Biodexa Pharmaceticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Biodexa Pharmaceticals's related companies. | 2023 | 2025 | 2026 (projected) | Interest Debt Per Share | 1.6K | 1.35 | 1.28 | Revenue Per Share | 1.2K | 1.4K | 1.3K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Biodexa Stock Analysis
When running Biodexa Pharmaceticals' price analysis, check to measure Biodexa Pharmaceticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biodexa Pharmaceticals is operating at the current time. Most of Biodexa Pharmaceticals' value examination focuses on studying past and present price action to predict the probability of Biodexa Pharmaceticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biodexa Pharmaceticals' price. Additionally, you may evaluate how the addition of Biodexa Pharmaceticals to your portfolios can decrease your overall portfolio volatility.